Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV000821315 | SCV000962069 | pathogenic | MHC class II deficiency | 2023-03-08 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 663446). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with CIITA-related conditions. This sequence change creates a premature translational stop signal (p.Gly655Argfs*94) in the CIITA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CIITA are known to be pathogenic (PMID: 8402893, 9099848, 26271388). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. |
| Revvity Omics, |
RCV000821315 | SCV003826767 | likely pathogenic | MHC class II deficiency | 2022-10-17 | criteria provided, single submitter | clinical testing |